Pharmaco-Therapeutic Study Of Shala(Shorea robusta Gaertn.f)Niryasa And Nagkeshara(Mesua ferrea Linn.) Churna In Management Of Sweta Pradara - A Comparative Study.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)
研究概览
简要总结
This is randomized interventional a Pharmaco-therapeutic Study Of Shala (Shorea robusta Gaertn.f) Niryasa and Nagkeshara (Mesua Ferrea Linn.) Churna in Management Of Sweta Pradara- A Comparative Study Total 60 Patients will be enrolled in the present study. Selected Patients will be divided into two groups on the basis of computer generated randomization.
Group A 30 Patients will be treated with Shala Niryasa Churna 2 gms along with lukewarm water orally before meals TDS for 6 weeks
Group B 30 Patients will be treated with Nagkeshara Churna 3 gms along with Takra orally before meals BD for 6 weeks
Follow up will be taken on 15th day then 30 th day and lastly on 45th day
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- Female
入选标准
- •1 Married Female Patients Of Age 18 to 55 Years 2 Patients Presenting With Complaints Of White Discharge Per Vginum 3 Patients Willing To Register And Sign The Consent Form.
排除标准
- •1 Unmarried female 2 Patient having any type of malignancy 3 Patient having positive VDRL HIV HbsAg Tuberculosis Pelvic inflammatory diseases and STDs 4 Pregnant women and Lactating Mothers 5 Patient having any Chronic systemic Illness 6 Age below 18 year and above 55 year.
结局指标
主要结局
Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)
时间窗: Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)
次要结局
- Assessment of change in the clinical parameters on 15th day(30th and 45th day)